TELA Bio (TELA) Other Non Operating Income (2018 - 2026)
TELA Bio's (TELA) quarterly Other Non Operating Income came in at $366000.0 in Q1 2026, down 23.59% year-on-year from $479000.0 in Q1 2025, and up 145.52% quarter-over-quarter from -$804000.0 in Q4 2025.
TELA Bio (TELA) Other Non Operating Income (2018 - 2026) Analysis & Trends
TELA Bio's Other Non Operating Income history runs 9 years deep, the most recent figure standing at $366000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 23.59% year-over-year to $366000.0 in Q1 2026; TTM through Mar 2026 was $93000.0, a 93.37% decrease from a year earlier, with the FY2025 full-year figure at $206000.0, down 85.49% from the prior year.
- Other Non Operating Income climbed to $366000.0 in Q1 2026 per TELA's latest filing, from -$804000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.2 million in Q4 2022 and bottomed at -$804000.0 in Q4 2025.
- The 5-year median for Other Non Operating Income is $366000.0 (2026), against an average of $305882.4.
- Biggest YoY gain for Other Non Operating Income was 2932.56% in 2022; the steepest drop was 586.36% in 2022.
- Year by year, Other Non Operating Income stood at $1.2 million in 2022, then tumbled by 39.82% to $733000.0 in 2023, then slumped by 61.12% to $285000.0 in 2024, then slumped by 382.11% to -$804000.0 in 2025, then surged by 145.52% to $366000.0 in 2026.
- Per Business Quant, the three latest TELA Other Non Operating Income figures stand at $366000.0 (Q1 2026), -$804000.0 (Q4 2025), and $152000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | TELA Bio | 38.36 Mn | -1.18 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 366,000.00 |
| Dec 31, 2025 | -804,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 379,000.00 |
| Mar 31, 2025 | 479,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 497,000.00 |
| Dec 31, 2023 | 733,000.00 |
| Sep 30, 2023 | 558,000.00 |
| Jun 30, 2023 | 870,000.00 |
| Mar 31, 2023 | 473,000.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | -195,000.00 |
| Jun 30, 2022 | -342,000.00 |
| Mar 31, 2022 | -107,000.00 |
| Dec 31, 2021 | -43,000.00 |
| Sep 30, 2021 | -127,000.00 |
| Jun 30, 2021 | -80,000.00 |